title: Physiological barriers to the oral delivery of curcumin.
abstract: Curcumin, a principal component from Curcuma longa, with antioxidant and anti-inflammatory activities was proposed as a potential candidate for the preventation and/or treatment of cancer and chronic diseases. However, curcumin could not achieve its expected therapeutic outcome in clinical trials due to its low solubility and poor bioavailability. The actual intestinal physiological barriers limiting curcumin absorption after oral administration have not been fully investigated. To identify the main barriers curtailing its absorption, in vitro permeability of curcumin and flux of its glucuronide were monitored in rat jejunum and Transwell grown Caco-2 cells. Curcumin was more permeable under acidic conditions, but the permeability was substantially below the permeability of highly permeable standards. Its efflux could not be inhibited by specific Pgp and MRP inhibitors. BCRP was found to participate in curcumin transport, but the Organic Anion Transporting Polypeptide (OATP) did not. The permeability of curcumin significantly increased when the structure of mucus was compromised. The inhibitor of curcumin metabolism, piperin, failed to act as a permeability enhancer. Piperin inhibited Pgp and MRP transporters and decreased the amount of glucuronide transported back into the intestine. Inclusion of piperin in curcumin-containing formulations is highly recommended as to inhibit curcumin glucuronidation and to increase the transport of formed glucuronides into the plasma, therefore increasing the probability of glucuronide distribution into target tissue and inter-convertion to curcumin. It would also be beneficial, if curcumin delivery systems could reversibly compromise the mucous integrity to minimize the non-specific binding of curcumin to its constituents.
authors: Faculty of Pharmacy, Ljubljana, Slovenia. katja.berginc@ffa.uni-lj.si
authors: K
authors: K
authors: Berginc
authors: J
authors: J
authors: Trontelj
authors: N Skalko
authors: NS
authors: Basnet
authors: A
authors: A
authors: Kristl
mesh_terms: D000465:Algorithms; D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D052117:Benzodioxoles / Q000494:pharmacology; D002021:Buffers; D018938:Caco-2 Cells; D002851:Chromatography, High Pressure Liquid; D003474:Curcumin / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D004355:Drug Stability; D020719:Glucuronides / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000378:metabolism; D007583:Jejunum / Q000378:metabolism; D013058:Mass Spectrometry; D008564:Membrane Potentials / Q000187:drug effects; D018408:Patch-Clamp Techniques; D010539:Permeability; D010880:Piperidines / Q000494:pharmacology; D053284:Polyunsaturated Alkamides / Q000494:pharmacology; D051381:Rats; D012995:Solubility
chemical_list: D000470:Alkaloids; D052117:Benzodioxoles; D002021:Buffers; D020719:Glucuronides; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D003474:Curcumin; C008922:piperine